| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | Director
3 companies
Hecht Beth is a See Remarks at XERS, with reported holdings spanning 3 companies. Recent filings cover 0 purchases and 14 sales. Those positions are worth an estimated $10.5M at current prices.
Our model assigns Hecht Beth a below-average insider score of 46/100, based on 6 past trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -0.2%.
Hecht Beth's largest disclosed position is in XERS as See Remarks, worth about $10.5M. The recent filings there lean toward selling, a net 240,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | XERS Xeris Biopharma Holdings, Inc. | See Remarks | Sell10b5-1 | 16,666 | $9.41 | $156,792.06 | -1.5% | - | - | |
| Sep 1, 2026 | XERS Xeris Biopharma Holdings, Inc. | See Remarks | Sell10b5-1 | 16,666 | $8.49 | $141,434.34 | -1.5% | - | - | |
| Aug 3, 2026 | XERS Xeris Biopharma Holdings, Inc. | See Remarks | Sell10b5-1 | 16,666 | $8.01 | $133,552.99 | -1.4% | - | - | |
| Jul 1, 2026 | XERS Xeris Biopharma Holdings, Inc. | See Remarks | Sell10b5-1 | 16,666 | $8.03 | $133,859.65 | -1.4% | +24.7% | - | |
| Jun 1, 2026 | XERS Xeris Biopharma Holdings, Inc. | See Remarks | Sell10b5-1 | 16,667 | $6.06 | $100,982.02 | -1.4% | +39.0% | - | |
| May 1, 2026 | XERS Xeris Biopharma Holdings, Inc. | See Remarks | Sell10b5-1 | 16,667 | $6.23 | $103,805.41 | -1.4% | +34.1% | - | |
| Apr 1, 2026 | XERS Xeris Biopharma Holdings, Inc. | See Remarks | Sell10b5-1 | 16,667 | $5.99 | $99,858.66 | -1.4% | +31.1% | - | |
| Mar 2, 2026 | XERS Xeris Biopharma Holdings, Inc. | See Remarks | Sell10b5-1 | 16,667 | $6.25 | $104,085.74 | -1.3% | +0.8% | - | |
| Feb 2, 2026 | XERS Xeris Biopharma Holdings, Inc. | See Remarks | Sell | 16,667 | $7.45 | $124,147.48 | -1.3% | -13.9% | - | |
| Jan 2, 2026 | XERS Xeris Biopharma Holdings, Inc. | See Remarks | Sell10b5-1 | 16,667 | $7.43 | $123,775.81 | -1.3% | -17.8% | - |